ClinicalTrials.govpublic full text
First-line Treatment of Advanced/unresectable DDLPS
dedifferentiated liposarcoma, soft tissue sarcoma (sts), liposomal doxorubicin, apatinib, camrelizumab, first line treatment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902162
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.